1. Issued in 2015 – Percutaneous Valve Registry

2. Percutaneous Valve Registry Annual report 2014

3. Issued in 2015 – Percutaneous Valve Registry Working group PercutaneousValve Registry 2014 Chair Johan Nilsson, MD, PhD, Umeå Deputy chair Jan Harnek, MD, PhD, Lund Swedish Society of Thoracic Surgery Peter Holm, MD, PhD, Uppsala Stefan James, MD, PhD, Uppsala Niels Erik Nielsen, MD, Linköping Petur Petursson, MD, Gothenburg Andreas Rück, MD, PhD, Stockholm Magnus Settergren, MD, PhD, Stockholm Leszek Zagozdzon, MD, Örebro

4. Issued in 2015 – Percutaneous Valve Registry Figure 1. TAVI Quality Index, per centre, 2014.

5. Issued in 2015 – Percutaneous Valve Registry Table 1. TAVI QI, per centre, 2014. Data on complications in Lund and Linköping could not be adjudicated (see text and Appendix for details).

6. Issued in 2015 – Percutaneous Valve Registry Figure 2. Number of TAVI procedures per centre and year, 2008–2014.

7. Issued in 2015 – Percutaneous Valve Registry Figure 3. Number of TAVI procedures per 100 000 inhabitants in the patient’s home county, 2014.

8. Issued in 2015 – Percutaneous Valve Registry Figure 4. Mean age of patients, per year, 2009–2014.

9. Issued in 2015 – Percutaneous Valve Registry Figure 5. Logistic EuroSCORE I, per centre and year, all patients, 2009–2014.

10. Issued in 2015 – Percutaneous Valve Registry Figure 6. Fluoroscopy time, per type of device and year, 2008–2014. Error bars represent standard deviations.

11. Issued in 2015 – Percutaneous Valve Registry Figure 7. Mean contrast agent volume per procedure (mL), per centre and year, 2008–2014.

12. Issued in 2015 – Percutaneous Valve Registry Figure 8. Number of procedures per access type and year, 2008–2014. Alternative access includes transapical, transaortic, and subclavian access.

13. Issued in 2015 – Percutaneous Valve Registry Figure 9. Number of procedures per access type and centre, 2014.

14. Issued in 2015 – Percutaneous Valve Registry Figure 10. Number of TAVI procedures per centre and year, 2008–2014.

15. Issued in 2015 – Percutaneous Valve Registry Figure 11. Aortic regurgitation severity assessed by postoperative echocardiography, graded as 0 (none), I (mild), II (moderate), or III (severe), 2014. Grading was done locally.

16. Issued in 2015 – Percutaneous Valve Registry Figure 12. Number and proportion of patients with need for a new permanent pacemaker after TAVI, per device type and year, 2008–2014.

17. Issued in 2015 – Percutaneous Valve Registry Figure 13. Number and proportion of patients with in-hospital stroke, per year, 2008–2014.

18. Issued in 2015 – Percutaneous Valve Registry Table 2. Number and proportion of selected intra-procedurale complications, per type of device, 2014.

19. Issued in 2015 – Percutaneous Valve Registry Table 3. Number and proportion of selected in-hospital (post-procedural) complications, per type of device, 2014.

20. Issued in 2015 – Percutaneous Valve Registry Figure 14. 30-day mortality after TAVI, per year, 2008–2014. Number above the bar.

21. Issued in 2015 – Percutaneous Valve Registry Figure 15. One-year mortality after TAVI, per year, 2008–2013. Number above the bar.

22. Issued in 2015 – Percutaneous Valve Registry Table 4. 30-day mortality for 2014, one-year mortality for 2013, logistic EuroSCORE I and number of cases for 2014, per centre.

23. Issued in 2015 – Percutaneous Valve Registry Figure 16. One-year survival after TAVI, per age group, 2008–2013.

24. Issued in 2015 – Percutaneous Valve Registry Figure 17. Four-year survival after TAVI, according to Kaplan-Meier, 2008–2014.